A Phase I Study of HW241045 in Healthy Subjects

NCT07593690 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis (IPF)

Interventions

DRUG: HW241045 Formulation A
DRUG: HW241045 Formulation B
DRUG: Placebo

Sponsor

Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.